Clinical Research Directory
Browse clinical research sites, groups, and studies.
Intravenous Oliceridine and Opioid-related Complications
Sponsor: The Cleveland Clinic
Summary
The investigator will evaluate the side effects of oliceridine.
Official title: Intravenous Oliceridine and Opioid-related Complications: VOLITION: A Multicenter Pilot Cohort Study
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
204
Start Date
2021-09-15
Completion Date
2024-01-10
Last Updated
2026-05-14
Healthy Volunteers
No
Conditions
Interventions
Oliceridine
Near the end of surgery, patients will be given ≤1.5 mg of oliceridine as a bolus. Postoperatively, patient-controlled analgesia (PCA) will be started with no background infusion, demand doses of 0.35 mg, with a 6 minute lock-out. Additional boluses (≤1 mg) of oliceridine will be given as deemed necessary (based on NRS score and clinical assessment of the patient) as soon as 15 minutes after the initial 1.5 mg loading dose. In addition to supplemental 1 mg bolus doses, the PCA demand dose can be increased to a maximum of 0.5 mg oliceridine.
Locations (3)
Wake Forest Bapist Medical Center
Winston-Salem, North Carolina, United States
Cleveland Clinic Fairview Hospital
Cleveland, Ohio, United States
Cleveland Clinic Main Campus
Cleveland, Ohio, United States